{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T16:09:23Z","timestamp":1775750963250,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Monit Comput"],"DOI":"10.1007\/s10877-025-01349-0","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T11:42:51Z","timestamp":1756122171000},"page":"1227-1236","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Relationship between effect site concentration of remimazolam at loss of consciousness and time to extubation: a prospective, single-centre, observational study"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2290-3764","authenticated-orcid":false,"given":"Kazuhiro","family":"Shirozu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Asada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinnosuke","family":"Takamori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taichi","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Yamaura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"issue":"1","key":"1349_CR1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/01.anes.0000267503.85085.c0","volume":"107","author":"GJ Kilpatrick","year":"2007","unstructured":"Kilpatrick GJ, McIntyre MS, Cox RF, et al. CNS 7056: a novel ultra-short-acting benzodiazepine. Anesthesiology. 2007;107(1):60\u20136. https:\/\/doi.org\/10.1097\/01.anes.0000267503.85085.c0.","journal-title":"Anesthesiology"},{"issue":"2","key":"1349_CR2","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1213\/ANE.0b013e318241f68a","volume":"115","author":"HR Wiltshire","year":"2012","unstructured":"Wiltshire HR, Kilpatrick GJ, Tilbrook GS, Borkett KM. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part II. Population pharmacokinetic and pharmacodynamic modeling and simulation. Anesth Analg. 2012;115(2):284\u201396. https:\/\/doi.org\/10.1213\/ANE.0b013e318241f68a.","journal-title":"Anesth Analg"},{"issue":"6","key":"1349_CR3","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/bja\/aeq260","volume":"105","author":"RN Upton","year":"2010","unstructured":"Upton RN, Somogyi AA, Martinez AM, Colvill J, Grant C. Pharmacokinetics and pharmacodynamics of the short-acting sedative CNS 7056 in sheep. Br J Anaesth. 2010;105(6):798\u2013809. https:\/\/doi.org\/10.1093\/bja\/aeq260.","journal-title":"Br J Anaesth"},{"issue":"4","key":"1349_CR4","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00540-020-02776-w","volume":"34","author":"M Doi","year":"2020","unstructured":"Doi M, Hirata N, Suzuki T, Morisaki H, Morimatsu H, Sakamoto A. Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial. J Anesth. 2020;34(4):491\u2013501. https:\/\/doi.org\/10.1007\/s00540-020-02776-w.","journal-title":"J Anesth"},{"issue":"4","key":"1349_CR5","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00540-020-02788-6","volume":"34","author":"M Doi","year":"2020","unstructured":"Doi M, Morita K, Takeda J, Sakamoto A, Yamakage M, Suzuki T. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase iib\/iii trial. J Anesth. 2020;34(4):543\u201353. https:\/\/doi.org\/10.1007\/s00540-020-02788-6.","journal-title":"J Anesth"},{"key":"1349_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2020.109899","volume":"66","author":"J Zhou","year":"2020","unstructured":"Zhou J, Leonowens C, Ivaturi VD, et al. Population pharmacokinetic\/pharmacodynamic modeling for remimazolam in the induction and maintenance of general anesthesia in healthy subjects and in surgical subjects. J Clin Anesth. 2020;66: 109899. https:\/\/doi.org\/10.1016\/j.jclinane.2020.109899.","journal-title":"J Clin Anesth"},{"issue":"4","key":"1349_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/jcph.1552","volume":"60","author":"LL Lohmer","year":"2020","unstructured":"Lohmer LL, Schippers F, Petersen KU, Stoehr T, Schmith VD. Time-to-event modeling for remimazolam for the indication of induction and maintenance of general anesthesia. J Clin Pharmacol. 2020;60(4):505\u201314. https:\/\/doi.org\/10.1002\/jcph.1552.","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"1349_CR8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s00540-021-03030-7","volume":"36","author":"K Shirozu","year":"2022","unstructured":"Shirozu K, Nobukuni K, Tsumura S, et al. Neurological sedative indicators during general anesthesia with remimazolam. J Anesth. 2022;36(2):194\u2013200. https:\/\/doi.org\/10.1007\/s00540-021-03030-7.","journal-title":"J Anesth"},{"issue":"4","key":"1349_CR9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00540-022-03079-y","volume":"36","author":"K Masui","year":"2022","unstructured":"Masui K, Stohr T, Pesic M, Tonai T. A population pharmacokinetic model of remimazolam for general anesthesia and consideration of remimazolam dose in clinical practice. J Anesth. 2022;36(4):493\u2013505. https:\/\/doi.org\/10.1007\/s00540-022-03079-y.","journal-title":"J Anesth"},{"issue":"1","key":"1349_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/00000542-199701000-00005","volume":"86","author":"CF Minto","year":"1997","unstructured":"Minto CF, Schnider TW, Shafer SL. Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application. Anesthesiology. 1997;86(1):24\u201333. https:\/\/doi.org\/10.1097\/00000542-199701000-00005.","journal-title":"Anesthesiology"},{"issue":"1","key":"1349_CR11","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bja.2025.02.038","volume":"135","author":"DJ Eleveld","year":"2025","unstructured":"Eleveld DJ, Colin PJ, Van den Berg JP, Koomen JV, Stoehr T, Struys M. Development and analysis of a remimazolam pharmacokinetics and pharmacodynamics model with proposed dosing and concentrations for anaesthesia and sedation. Br J Anaesth. 2025;135(1):206\u201317. https:\/\/doi.org\/10.1016\/j.bja.2025.02.038.","journal-title":"Br J Anaesth"},{"issue":"6","key":"1349_CR12","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00540-022-03099-8","volume":"36","author":"K Masui","year":"2022","unstructured":"Masui K, Hagihira S. Equilibration rate constant, k(e0), to determine effect-site concentration for the Masui remimazolam population pharmacokinetic model in general anesthesia patients. J Anesth. 2022;36(6):757\u201362. https:\/\/doi.org\/10.1007\/s00540-022-03099-8.","journal-title":"J Anesth"},{"issue":"2","key":"1349_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/YPG.0000000000000306","volume":"32","author":"VY Skryabin","year":"2022","unstructured":"Skryabin VY, Zastrozhin M, Torrado M, et al. Effects of CYP2C19*17 genetic polymorphisms on plasma and saliva concentrations of diazepam in patients with alcohol withdrawal syndrome. Psychiatr Genet. 2022;32(2):67\u201373. https:\/\/doi.org\/10.1097\/YPG.0000000000000306.","journal-title":"Psychiatr Genet"},{"issue":"4","key":"1349_CR14","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/clpt.1989.41","volume":"45","author":"DJ Greenblatt","year":"1989","unstructured":"Greenblatt DJ, Ehrenberg BL, Gunderman J, et al. Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo. Clin Pharmacol Ther. 1989;45(4):356\u201365. https:\/\/doi.org\/10.1038\/clpt.1989.41.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"1349_CR15","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/ALN.0000000000003102","volume":"132","author":"A Eisenried","year":"2020","unstructured":"Eisenried A, Schuttler J, Lerch M, Ihmsen H, Jeleazcov C. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part II. Pharmacodynamics of electroencephalogram effects. Anesthesiology. 2020;132(4):652\u201366. https:\/\/doi.org\/10.1097\/ALN.0000000000003102.","journal-title":"Anesthesiology"}],"container-title":["Journal of Clinical Monitoring and Computing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10877-025-01349-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10877-025-01349-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10877-025-01349-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T03:50:54Z","timestamp":1764820254000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10877-025-01349-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":15,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1349"],"URL":"https:\/\/doi.org\/10.1007\/s10877-025-01349-0","relation":{},"ISSN":["1573-2614"],"issn-type":[{"value":"1573-2614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This observational, prospective study was approved by the Clinical Research Ethics Committee of Kyushu University, Fukuoka, Japan (approval number 23260-00, Chairman Professor T. Ninomiya) on 11 July 2023. All aspects of the study protocol complied with the Declaration of Helsinki (2013).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all patients before enrolment.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}